Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus
Acta Neuropsychiatrica · 2024
DOI: 10.1017/neu.2023.13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neuropsychiatrica, 2024. Verfasst von Yane Costa Chaves und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Biological Science Sector, Federal University of Paraná, Curitiba, Paraná, Brazil. Hauptthemen laut MEDLINE: Cannabidiol, Fear, Memory Consolidation, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objectives
In view of the neuroprotective characteristic of cannabidiol (CBD) and its beneficial action on aversive memory in non-diabetic animals, we aimed to investigate in animals with experimentally induced type-1 diabetes mellitus (T1DM) whether CBD treatment would be able to impair the contextual fear memory consolidation, its generalisation and whether the effect would be lasting. We also investigated the CBD effect on anxiety-like responses.
Methods
After T1DM induction, animals received single or more prolonged treatment with CBD and were submitted to the contextual fear conditioning test. As expression of activity-regulated cytoskeletal-associated (Arc) protein is necessary for memory consolidation, we evaluated its expression in the dorsal hippocampus (DH). For evaluating anxiety-related responses, animals were submitted to the elevated plus maze test (EPMT), in which the time and number of entries in the open arms were used as anxiety index.
Results
A single injection of CBD impaired the contextual fear memory consolidation and its generalisation, which was evaluated by exposing the animal in a neutral context. This single injection was able to reduce the elevated expression of Arc in the DH from these animals. Interestingly, more prolonged treatment with CBD also impaired the persistence of context-conditioned fear memory and induced an anxiolytic-like effect, as the treated group spent more time in the open arms of the EPMT.
Conclusion
CBD interferes with contextual fear memory and the dosage regimen of treatment seems to be important. Moreover, we cannot rule out the involvement of emotional aspects in these processes related to fear memory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Biological Science Sector, Federal University of Paraná, Curitiba, Paraná, Brazil.
- Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Neuroscience and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo, Brazil.
- National Institute of Science and Technology for Translational Medicine (INCT-TM-CNPq), Ribeirão Preto, São Paulo, Brazil.
ORCID-Profile: Janaína Menezes Zanoveli
Zitieren
APA
Chaves, Y. C., Raymundi, A. M., Waltrick, A. P. F., de Souza Crippa, J. A., Stern, C. A. J., da Cunha, J. M., & Zanoveli, J. M. (2024). Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus. Acta Neuropsychiatrica. https://doi.org/10.1017/neu.2023.13
Vancouver
Chaves YC, Raymundi AM, Waltrick APF, de Souza Crippa JA, Stern CAJ, da Cunha JM, et al. Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus. Acta Neuropsychiatrica. 2024. doi:10.1017/neu.2023.13
BibTeX
@article{Chaves2024,
author = {Chaves, Yane Costa and Raymundi, Ana Maria and Waltrick, Ana Paula Farias and de Souza Crippa, José Alexandre and Stern, Cristina Aparecida Jark and da Cunha, Joice Maria and Zanoveli, Janaína Menezes},
title = {Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus},
journal = {Acta Neuropsychiatrica},
year = {2024},
doi = {10.1017/neu.2023.13}
}
EUVIMED